Skip to main content
Market intelligence
REPLHealthcare

Replimune Group Inc insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Jun 1, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 1, 2026Christopher SarchiChief Commercial OfficerSale12,000$9.24$110,880
May 18, 2026Konstantinos XynosChief Medical OfficerSale14,023$5.08$71,237
May 18, 2026Andrew SchwendenmanChief Accounting OfficerSale7,894$5.08$40,102